MANGALAM DRUGS & ORGANICS LTD. - Outcome Of Board Meeting Held On Friday, November 11, 2022

Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 11, 2022 transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the period ended September 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations;